Scarica l'app Stockscreener
1.04
0.97%
0.01
Dopo l'orario di chiusura:
1.03
-0.01
-0.96%
Tscan Therapeutics Inc Azioni (TCRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
2.23%
2.567
|
2.511 | 3.076 | 2.171 | 0.665 |
Operating Expenses
|
33.21%
26.43
|
39.56 | 41.73 | 38.42 | 37.38 |
| Interest Income/Expense |
0.43%
0.702
|
0.699 | 0.689 | 0.679 | 0.784 |
| Benefits Costs and Expenses |
25.54
|
- | - | 36.30 | 36.47 |
| Costs And Expenses |
35.43%
25.54
|
39.56 | 41.73 | 36.30 | 36.47 |
| Operating Income/Loss |
35.61%
-23.86
|
-37.05 | -38.65 | -36.25 | -36.71 |
| Income/Loss From Continuing Operations Before Tax |
1,015%
-22.98
|
2.511 | 3.076 | -34.13 | -35.81 |
| Income/Loss From Continuing Operations After Tax |
35.66%
-22.98
|
-35.71 | -36.95 | -34.13 | -35.81 |
|
Net Income/Loss
|
35.66%
-22.98
|
-35.71 | -36.95 | -34.13 | -35.81 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.98%
0.0285
|
129.84 | 129.73 | 129.68 | 2.9545 |
| Diluted Average Shares |
99.98%
0.0285
|
129.84 | 129.73 | 129.68 | 2.9545 |
| Basic Earnings Per Share |
35.71%
-0.18
|
-0.28 | -0.28 | -0.26 | -0.30 |
| Diluted Earnings Per Share |
35.71%
-0.18
|
-0.28 | -0.28 | -0.26 | -0.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):